Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesZivo Bioscience Inc

Zivo Bioscience Inc

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
8.12 USD 0.87 ( 12.00%)
Last update at 2026-11-05T21:00:00Z
VOLUME
35
Market Cap
17.28M

Momentum Score

…

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
7.25
Low
8.12
High
52 Week Price Range
1.11
Low
17.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Zivo Bioscience (NASDAQ: ZIVO) is a small life‑sciences company with limited public disclosures, so detailed operations and product mix are not extensively reported. Long‑term growth may depend on commercial adoption of its technologies, expansion into target markets, and successful scale‑up, which could make it attractive to investors seeking niche biotech/nutrition exposure.
The primary investment risk is high execution and financing uncertainty typical of small, thinly reported biotechs, including potential capital needs, regulatory hurdles, and limited operating history.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
7.25
Dividend Yield
-
Revenue TTM
0.21M
Revenue Per Share
0.06
Gross Profit TTM
0.07M
Debt / Equity
-0.17
ROE
-3956.02%
Net Debt
0.57M
ROCE
277.91%
Diluted EPS TTM
-2.18

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -9.89M -13.38M -7.78M -8.75M -9.16M
Net income -9.89M -13.38M -7.78M -8.75M -9.40M
Selling general administrative - 10.28M 5.90M 6.49M 6.93M
Gross profit 0.04M 0.05M 0.01M - -
Ebit -9.85M -13.36M -7.26M -8.73M -9052.60M
Ebitda -9.84M -13.26M -6.82M -8.73M -9.05M
Depreciation and amortization 0.02M 0.10M 0.44M - -0.56M
Operating income -9.85M -13.36M -7.26M -8.73M -9.05M
Other operating expenses 9.97M 13.52M 7.29M 8.73M 9.05M
Interest expense 0.03M 0.02M 0.51M 0.01M 0.23M
Net interest income - -0.02M -0.51M -0.01M -0.23M
Income tax expense - - -0.17M - 0.23M
Total revenue 0.12M 0.16M 0.03M 0.00M 0.00M
Total operating expenses 9.89M 13.41M 7.27M 8.73M 9.05M
Cost of revenue 0.08M 0.11M 0.02M - -
Total other income expense net -0.04M -0.02M -0.51M -0.01M -0.11M
Net income from continuing ops - -13.38M -8.51M -8.75M -9.16M
Net income applicable to common shares - - - -8.75M -9.16M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.66M 1.64M 0.56M 2.12M 8.99M
Other current assets 0.07M 0.09M 0.15M 0.10M 58.08M
Total liab 4.41M 2.16M 2.76M 2.13M 2.95M
Total stockholder equity -3.75M -0.51M -2.21M -0.01M 6.04M
Other current liab 2.56M 1.36M 1.66M 1.20M 2.04M
Common stock 0.00M 0.00M 0.00M 0.01M 0.01M
Capital stock - 0.00M 0.00M 0.01M 0.01M
Retained earnings -146.86M -136.97M -123.58M -115.80M -108.23M
Other assets - 0.00M - 0.03M 0.00M
Cash 0.07M 1.54M 0.27M 1.80M 8.90M
Total current liabilities 4.21M 2.04M 2.76M 2.03M 2.95M
Current deferred revenue - - -0.24M - -
Net debt 0.57M -1.29M 0.07M -1.35M -8.65M
Short term debt 0.43M 0.14M 0.35M 0.34M 0.26M
Short long term debt - 0.14M 0.24M 0.24M 0.24M
Short long term debt total 0.64M 0.25M 0.35M 0.45M 0.26M
Other stockholder equity 143.11M 136.45M 121.37M 115.78M 114.26M
Property plant equipment - - - 0.19M 0.03M
Total current assets 0.40M 1.64M 0.43M 1.90M 8.96M
Net tangible assets - - - -0.01M 6.04M
Net receivables - 0.00M 0.00M - -
Long term debt - 0.12M - - -
Inventory 0.26M - - - -
Accounts payable 1.21M 0.55M 0.99M 0.49M 0.65M
Non currrent assets other 0.01M 0.01M 0.03M 0.03M 0.00M
Non current assets total 0.26M 0.01M 0.13M 0.22M 0.03M
Capital lease obligations - 0.00M 0.11M 0.21M 0.02M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M 0.00M 0.00M 0.00M
Change to liabilities - - - -0.16M -0.82M
Net borrowings - -0.02M 0.00M - -
Total cash from financing activities 1.81M 5.58M 4.28M -0.63M 15.57M
Change to operating activities - - - -0.19M 0.43M
Net income -9.89M -13.38M -7.78M -8.75M -9.16M
Change in cash -1.48M 1.27M -1.52M -7.10M 8.76M
Begin period cash flow 1.54M 0.27M 1.80M 8.90M 0.14M
End period cash flow 0.07M 1.54M 0.27M 1.80M 8.90M
Total cash from operating activities -3.29M -4.31M -5.80M -7.10M -6.80M
Issuance of capital stock - 5.60M 0.64M 0.00M 17.21M
Depreciation 0.02M 0.10M 0.44M -0.77M -555.75M
Change to inventory -0.26M - 1.11M - -
Change to account receivables 0.00M 0.00M -0.00M - -
Other cashflows from financing activities - 5.60M 3.64M 0.63M -1.45M
Change to netincome - - - 2.00M 2.75M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 1.63M -0.50M 1.28M -0.36M -0.39M
Stock based compensation - 9.47M 0.87M 2.69M 3.38M
Other non cash items 4.96M 0.10M -0.61M 0.08M -0.62M
Free cash flow -3.29M -4.31M -5.80M -7.10M -6.80M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ZIVO
Zivo Bioscience Inc		 0.87
12.00%		 8.12 - - 82.68 21.13 86.33 -3.01
NVO
Novo Nordisk A/S		 0.01
0.02%		 40.31 41.58 31.15 2.13 32.99 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 4.59
0.85%		 547.09 30.22 24.27 10.36 6.50 9.99 24.66
REGN
Regeneron Pharmaceuticals Inc		 1.45
0.16%		 904.35 29.07 20.12 7.57 3.82 6.95 19.42
ARGNF
argenx SE		 -
-%		 900.30 45.77 31.25 13.84 7.12 11.38 36.06

Profile*

Zivo Bioscience Inc

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

2125 Butterfield Drive, Troy, MI, United States, 48084

248 452 9866

https://www.zivobioscience.com

7

Name Title Year Born
Mr. John B. Payne Pres, CEO & Chairman 1948
Mr. Keith R. Marchiando CFO, Treasurer & Sec. 1962
Mr. John B. Payne President, CEO & Chairman of the Board 1948
Mr. Keith R. Marchiando CFO, Treasurer & Secretary 1962
Dr. Harlan L. Miller III Vice President of Technology & Global Supply NA
Mr. John Bernard Payne President, CEO & Chairman of the Board 1948

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…